Related Experiment Video

Updated: Aug 8, 2026

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

Membrane-interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp120 binding to

L Krugner-Higby1, D Goff, T Edwards

  • 1Department of Comparative Medicine, Wake Forest University Medical Center, Winston-Salem, North Carolina 27157-1064, USA.

AIDS Research and Human Retroviruses
|June 1, 1995
PubMed

Insights

Phospholipid analogs (CP-51, CP-92) do not affect HIV-1 protein processing but inhibit viral binding to CD4+ cells and cell fusion. These compounds show potential for blocking HIV-1 spread and AIDS pathogenesis by altering cell membranes and viral envelopes.

Area of Science:

  • Virology
  • Biochemistry
  • Immunology

Background:

  • Membrane-interactive phospholipids (PLs) are known to impact late-stage HIV-1 replication.
  • Previous studies evaluated PLs for in vitro activity against HIV-1.

Purpose of the Study:

  • To investigate the effects of PL analogs on HIV-1 protein processing, CD4 receptor binding, and HIV-1-induced cell fusion.
  • To explore the potential of PL compounds in blocking HIV-1 spread and AIDS pathogenesis.

Main Methods:

  • Assessed the impact of CP-51 and CP-92 on HIV-1 protein synthesis and processing (gp160/gp120, pr51, p24, p17).
  • Evaluated the binding capacity of progeny HIV-1 particles to CD4+ cells.
  • Measured the inhibition of syncytium formation and viral gp160/gp120 binding to CD4+ cells and monoclonal antibodies.

Main Results:

  • CP-51 and CP-92 did not affect HIV-1 protein synthesis or processing, including myristoylation.
  • HIV-1 particles produced in CP-92 treated cells showed reduced binding to CD4+ cells.
  • Both CP-51 and CP-92 inhibited cell fusion (syncytium formation) and reduced viral gp160/gp120 binding.

Conclusions:

  • The anti-HIV-1 activity of PL compounds appears to stem from alterations to cell surface membranes and viral envelopes.
  • PL compounds represent a novel class of membrane-interactive agents with potential therapeutic applications against HIV-1 infection and AIDS progression.

More Related Videos

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion07:22

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion

Published on: August 14, 2018

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...